Specialty Pharmacy News – Drug Store News #generic #drug #companies

Posted On Jun 14 2017 by

#pharmacy news # Specialty Pharmacy News Two recent unanimous approval recommendations from FDA advisory committees regarding biosimilars is a signal of growing scientific acceptance and understanding of the biosimilar regulatory pathway, suggested The National Law Review in a report Tuesday. The National Law Review has created a chart summarizing pending and approved BLAs for biosimilars using publicly available information, the publication noted, but there are still two barriers to entry. As biosimilars gain FDA approval, patent issues remain a barrier and the exorbitant R D cost prevent significant price disparities. Accordingly, insurers may be slow to add biosimilars to the …


Pharmaceutical Distribution Software from IBS #eli #lilly #pharma

Posted On Jun 14 2017 by

#pharma software # Pharmaceutical Distribution Software Industry Trends The pharmaceutical market is in constant change, and the demand to continuously adapt expansive supporting systems is extreme. As companies grow through mergers, acquisitions and alliances, it becomes increasingly important to have a system that is easy to maintain in multiple facilities, locations, platforms, regions and languages. Pharmaceutical distribution places a heavy burden on the operational and logistics resources of any company. Industry-specific regulations and institutional requirements, forecasting, procurement, customer service, picking, dispatch and special treatment of physical inventory can all place a burden on logistical decisions. Add to that low margins, …


The Top 5 Small-Cap Biotechnology Stocks for 2016 (EXEL, LXRX, MNKD, MNTA, VNDA) #jazz #pharma

Posted On Jun 14 2017 by

#small pharma companies # The Top 5 Small-Cap Biotechnology Stocks for 2016 (EXEL, LXRX, MNKD, MNTA, VNDA) The biotechnology sector is responsible for many discoveries and innovations that have come to health care. Biotechnology companies have a sole purpose of finding treatments for many of the diseases that plague society. These companies spend billions of dollars in research and development. most of the time finding little success. However, when a treatment is found and patients respond in a positive manner, it could result in blockbuster profits. Unlike large-cap biotechnology companies such as Amgen or Gilead, small-cap companies operate on a …


AstraZeneca – Research-Based BioPharmaceutical Company #pharma #net

Posted On Jun 14 2017 by

#drug research companies # AstraZeneca live at ERS 2016 Meet Chris Rhodes, a renowned leader in the field of diabetes and obesity research I grew up in an artistic musical family, which instilled in me very early on the essence of creativity. Science requires original thinking, and cultivating and using that creativity is fundamental to innovation and momentous discovery . AstraZeneca’s ambitions for personalised healthcare go far beyond treating cancer At AstraZeneca, personalised healthcare is about matching medicines to the patients most likely to benefit from them. The approach involves a detailed understanding of the biology of a disease, identifying …


Top MBA Programs for Healthcare #pharma #brands

Posted On Jun 14 2017 by

#pharma mba # Top Business Schools for Healthcare / Pharma / Biotech 2015 For students working or hoping to work in the health fields, an MBA can prepare them for various functional roles – like marketing, business development, or strategy – at companies in the healthcare services, life sciences, pharma, and biotech industries. Focusing on healthcare electives in business school can also help MBA grads land internships and jobs at nonprofit organizations, or as consultants, investment bankers, and venture capitalists focused on health care. BU offers a two-year, specialized Health Sector MBA (HSM) that leads to internships and jobs in …


Indian Pharmaceuticals Industry Analysis #swiss #pharmaceutical #companies

Posted On Jun 14 2017 by

#pharmaceutical industry research # Indian Pharmaceuticals Industry Analysis Increasing investments in the sector The Indian pharmaceuticals market increased at a CAGR of 17.46 per cent in 2015 from US$ 6 billion in 2005 and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020. By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size. India s cost of production is significantly lower than that of the US and almost half of that of Europe. It gives a competitive edge …


Home – PPMA Pakistan Pharmaceuticals Manufacturers – Association #hitech #pharma

Posted On Jun 14 2017 by

#pharmaceutical manufacturers # Central Chairman Message Pakistan Pharma Industry is very vibrant and dynamic comprising more than 700 units. It is a knowledge based industry. It s going through a transition phase of modernization to cater local Pharmaceutical requirements and to access more regulated market like Europe and USA. Currently Pharma industry in fulfilling more than 95% of the domestic Pharmaceutical requirements. Our goal is ensure availability of quality medicines to all at reasonable price and to enhance exports of the country by accessing more value added markets of Europe and USA. Zonal Chairman North Message Pharmaceutical industry plays a …


Top Pharmaceutical Companies in India, List of Best Pharma Company, Big #inspire #pharma

Posted On Jun 14 2017 by

#pharmaceutical manufacturers # Pharmaceutical Companies in India Increasing investments in the sector The Indian pharmaceuticals market increased at a CAGR of 17.46 per cent in 2015 from US$ 6 billion in 2005 and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020. By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size. India s cost of production is significantly lower than that of the US and almost half of that of Europe. It gives a competitive edge to …


Humanwell Healthcare, PuraCap Acquire Epic Pharma – Contract Pharma #pharma #conference

Posted On Jun 14 2017 by

#epic pharma # Related Breaking News Humanwell Healthcare Group and PuraCap Pharmaceutical have acquired Epic Pharma for $550 million. The acquisition will further establish Humanwell and PuraCap in the U.S. generics market and expand their existing commercial and manufacturing capabilities. The acquisition of Epic will provide a robust generic product portfolio, which includes tablets, 2-piece capsules and powder dosage form products as well as a future product portfolio that will include a series of controlled drug substances. Humanwell and PuraCap will acquire Epic s balanced and diversified portfolio, which currently consists of 15 marketed generic products and a pipeline of …


Pharmaceutical industry research #medical #market #research

Posted On Jun 14 2017 by

#pharmaceutical industry research # Pharmaceutical Industry in the U.S. U.S. Pharmaceutical Industry – Statistics Facts Statistics and facts about the Pharmaceutical Industry in the U.S. The U.S. pharmaceutical market is the world’s most important national market. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. The United States alone holds some 40 percent of the global pharmaceutical market. In 2014, this share was valued around 365 million U.S. dollars. Many of the global top companies are located in the United States. In 2014, six out of the top eleven companies were U.S.-based. The largest U.S. companies …